NASDAQ: LNTH · Health Care / Biotechnology: In Vitro & In Vivo Diagnostic Substances

Lantheus Holdings Inc.

How Lantheus Holdings Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$6.5B

Price

$100.32

P/E

23.8

EPS (TTM)

$4.22

1-year return

79.5%

Dividend yield

0.0%

52-week range

$53.59–$100.39

Compared with

• Biotechnology: In Vitro & In Vivo Diagnostic Substances industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources